BZPEER
More

Discover

About BZPEERSearchGraph

Research tools

HomeCollectionsResearchCollaborationPublish

Network

ExpertsCommunities

Opportunities

Listings

Account

Log inCreate account
Log inCreate account

Source author record

Emma Snively

Explore this author’s publications, collaborators and research topics. This catalog record has not been claimed by its author.

ResearcherUnclaimed source record
physics.acc-phhep-exphysics.med-ph

Catalog footprint

Research overview

2works
3topics
4close collaborators

Actions

Is this your work?

Log in to claim
Open graphBrowse papers

Published work

2 publications

preprint2022arXiv

C3^3 Demonstration Research and Development Plan

C3^3 is an opportunity to realize an e+^+e−^- collider for the study of the Higgs boson at s=250\sqrt{s} = 250 GeV, with a well defined upgrade path to 550 GeV while staying on the same short facility footprint. C3^3 is based on a fundamentally new approach to normal conducting linear accelerators that achieves both high gradient and high efficiency at relatively low cost. Given the advanced state of linear collider designs, the key system that requires technical maturation for C3^3 is the main linac. This white paper presents the staged approach towards a facility to demonstrate C3^3 technology with both Direct (source and main linac) and Parallel (beam delivery, damping ring, ancillary component) R&D. The white paper also includes discussion on the approach for technology industrialization, related HEP R&D activities that are enabled by C3^3 R&D, infrastructure requirements and siting options.

Open access
preprint2022arXiv

Transformative Technology for FLASH Radiation Therapy: A Snowmass 2021 White Paper

Conventional cancer therapies include surgery, radiation therapy, chemotherapy, and, more recently, immunotherapy. These modalities are often combined to improve the therapeutic index. The general concept of radiation therapy is to increase the therapeutic index by creating a physical dose differential between tumors and normal tissues through precision dose targeting, image guidance, and high radiation beams that deliver radiation dose with high conformality, e.g., protons and ions. However, treatment and cure are still limited by normal tissue radiation toxicity, with many patients experiencing acute and long-term side effects. Recently, however, a fundamentally different paradigm for increasing the therapeutic index of radiation therapy has emerged, supported by preclinical research, and based on the FLASH radiation effect. FLASH radiation therapy (FLASH-RT) is an ultra-high dose-rate delivery of a therapeutic radiation dose within a fraction of a second. Experimental studies have shown that normal tissues seem to be universally spared at these high dose rates, whereas tumors are not. The dose delivery conditions are not yet fully characterized. Still, it is currently estimated that large doses of 10 Gy or more delivered in 200 ms or less produce normal tissue sparing effects yet effectively kill tumor cells. There is a great opportunity, but also many technical challenges, for the accelerator community to create the required dose rates with novel and compact accelerators to ensure the safe delivery of FLASH radiation beams.

Open access

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.